For the Inventor, By the Inventor

Enter assignee name

Blacksburg, VA, United States of America

Intrexon Corporation

USPTO Granted Patents = 121

% Expired Patents = 77.7

CIPO Patents = 25

EPO Patents = 48

Trademarks = 2

Forward Citations = 936

Loading Chart...

Loading Chart...

82 inventors (with patents filed for the assignee):

Thomas David Reed (41 out of 48 patents)

Robert Eugene Hormann (35 out of 44 patents)

Subba Reddy Palli (30 out of 36 patents)

4. Dean Ervin Cress (17 out of 21 patents)

5. Orestes Chortyk (14 out of 14 patents)

6. Colin M Tice (14 out of 68 patents)

7. Amy Hobbs Atzel (12 out of 13 patents)

8. Glenn Richard Carlson (10 out of 19 patents)

9. Mohan Basavaraju Kumar (8 out of 10 patents)

10. Tarlochan Singh Dhadialla (8 out of 11 patents)

11. Inna Shulman (7 out of 23 patents)

12. David W Potter (7 out of 8 patents)

13. Andrew Meyer (7 out of 7 patents)

14. Thomas R Opie (7 out of 10 patents)

15. Robert Beech (6 out of 8 patents)

Core Competencies:

Ecdysone Receptor

Gene Expression

Biotherapeutics

Serine Recombinases

Diacylhydrazine

Immunomodulators

Transgene Expression

Modulation

Protein Production

Chimeric Receptors

Ligands

Disease Diagnosis

121 patents: Sort by Forward Citations

1. 10851119 - Boron-containing diacylhydrazines (2020-12-01),

2. 10648003 - Site-specific serine recombinases and methods of their use (2020-05-12),

3. 10633361 - Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex (2020-04-28),

4. 10584351 - Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof (2020-03-10),

5. 10570158 - Boron-containing diacylhydrazine compounds (2020-02-25),

6. 10501405 - Crystalline diacylhydrazine and the use thereof (2019-12-10),

7. 10464951 - Boron-containing diacylhydrazines (2019-11-05),

8. 10314926 - Therapeutic gene-switch constructs and bioreactors for the expression of biotherapeutic molecules, and uses thereof (2019-06-11),

9. 10190124 - Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system (2019-01-29),

10. 10131916 - Regulatory element for heterologous protein production in the fruiting body of filamentous fungi (2018-11-20),

11. 10087231 - Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system (2018-10-02),

12. 10081817 - Site-specific serine recombinases and methods of their use (2018-09-25),

13. 10046049 - Engineered cells expressing multiple immunomodulators and uses thereof (2018-08-14),

14. 10036026 - Methods for dynamic vector assembly of DNA cloning vector plasmids (2018-07-31),

15. 9944659 - Boron-containing diacylhydrazine compounds (2018-04-17),

Company Overview

Intrexon Corporation, headquartered in Blacksburg, VA, specializes in gene expression modulation, focusing on innovative biotherapeutics. The company leverages advanced technologies such as the Ecdysone Receptor and Serine Recombinases to develop solutions that enhance transgene expression and immunomodulation. Intrexon's expertise in diacylhydrazine compounds and gene modulation positions it at the forefront of biotechnological advancements, aiming to address complex health challenges through tailored therapeutic approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

121 Patents

#3 in Blacksburg, VA

#55 in Virginia

#3,200 in US

#6,618 in the World

Blacksburg, VA, United States of America

Intrexon Corporation

Forward Citations = 936

82 inventors:

Thomas David Reed (41 out of 48 patents)

Robert Eugene Hormann (35 out of 44 patents)

Subba Reddy Palli (30 out of 36 patents)

4. Dean Ervin Cress (17 out of 21 patents)

5. Orestes Chortyk (14 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intrexon Corporation. Retrieved from https://idiyas.com/company/intrexon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…